公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2021 | Community-Based Gastric Cancer Screening Coupled With a National Colorectal Cancer Screening Program: Baseline Results | YI-CHIA LEE ; TSUNG-HSIEN CHIANG ; HAN-MO CHIU ; MING-SHIANG WU ; Yeh, Yen-Po; Hsiu-Hsi Chen, Tony; Li-Sheng Chen S.; Ming-Fang Yen A.; Ching-Yuan Fann J.; Yueh-Hsia Chiu S.; Hsu C.-Y.; Chuang S.-L.; Chou K.-C.; Su W.-W.; Chen S.-T.; Liao C.-S.; Lin Y.-M.; Chang H.-C.; Hu T.-H.; YU-JEN FANG ; CHANG-CHUAN CHAN ; Collaborators of the Taiwan Community-Based Integrated Screening Group | Gastroenterology | 7 | 7 | |
2020 | Comparison of DNA stabilizers and storage conditions on preserving fecal microbiota profiles | CHIEH-CHANG CHEN ; WEI-KAI WU ; Chang, Chih-Min; Panyod, Suraphan; TZU-PIN LU ; JYH-MING LIOU ; YU-JEN FANG ; ERIC YAO-YU CHUANG ; MING-SHIANG WU | Journal of the Formosan Medical Association = Taiwan yi zhi | 18 | 13 | |
2020 | Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial | CHIEH-CHANG CHEN ; Luo J.-C.; YU-JEN FANG ; Lee J.-Y.; Kuo C.-C.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Bair M.-J.; Chen P.-Y.; Chou C.-K.; Chen C.-Y.; Chang C.-Y.; Hsu Y.-C.; Tseng C.-H.; WEN-FENG HSU ; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; MEI-JYH CHEN ; CHIA-TUNG SHUN ; Liu T.-Y.; YI-CHIA LEE ; Liou§ J.-M.; MING-SHIANG WU ; and for the Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Therapeutic Advances in Gastroenterology | 5 | 6 | |
2012 | Computer-generated surface and tone enhancements to distinguish neoplastic from non-neoplastic colon polyps less than 1 cm in diameter | MING-LUN HAN ; YI-CHIA LEE ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Lee J.-Y.; Lin T.-L.; Lin L.-W.; PING-HUEI TSENG ; MING-SHIANG WU ; HSIU-PO WANG | International Journal of Colorectal Disease | 4 | 3 | |
2016 | Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial | JYH-MING LIOU ; YU-JEN FANG ; CHIEH-CHANG CHEN ; Bair, Ming-Jong; Chang, Chi-Yang; YI-CHIA LEE ; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; Tseng, Cheng-Hao; Hsu, Yao-Chun; Lee, Ji-Yuh; Yang, Tsung-Hua; Luo, Jiing-Chyuan; Chang, Chun-Chao; Chen, Chi-Yi; Chen, Po-Yueh; CHIA-TUNG SHUN ; WEN-FENG HSU ; Hu, Wen-Hao; YEN-NIEN CHEN ; Sheu, Bor-Shyang; Lin, Jaw-Town; Wu, Jeng-Yih; El-Omar, Emad M; MING-SHIANG WU | Lancet (London, England) | 120 | 112 | |
2022 | Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysis | MEI-JYH CHEN ; Bair, Ming-Jong; Chen, Po-Yueh; Lee, Ji-Yuh; Yang, Tsung-Hua; YU-JEN FANG ; CHIEH-CHANG CHEN ; Chang, An-Ti; Hsiao, Wang-De; Yu, Jian-Jyun; Kuo, Chia-Chi; Chiu, Min-Chin; Kun-Pei Lin ; Tsai, Min-Horn; Hsu, Yao-Chun; Chou, Chu-Kuang; Chen, Chi-Yi; JAW-TOWN LIN ; YI-CHIA LEE ; MING-SHIANG WU ; JYH-MING LIOU ; forthe Taiwan Gastrointestinal Disease; Helicobacter Consortium | Helicobacter | 7 | 6 | |
2015 | Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria | YU-JEN FANG ; JYH-MING LIOU ; CHIEH-CHANG CHEN ; Lee J.-Y.; Hsu Y.-C.; MEI-JYH CHEN ; PING-HUEI TSENG ; CHIEN-CHUAN CHEN ; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; HSIU-PO WANG ; Luo J.-C.; Lin J.-T.; CHIA-TUNG SHUN ; MING-SHIANG WU | Gut | 66 | 51 | |
2018 | Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection | Liou, Jyh-Ming; Chen, Po-Yueh; Luo, Jiing-Chyuan; Lee, Ji-Yuh; CHIEH-CHANG CHEN ; YU-JEN FANG ; Yang, Tsung-Hua; Chang, Chi-Yang; Bair, Ming-Jong; MEI-JYH CHEN ; Hsu, Yao-Chun; WEN-FENG HSU ; Chang, Chun-Chao; JAW-TOWN LIN ; CHIA-TUNG SHUN ; El-Omar, Emad M.; MING-SHIANG WU ; Liou, Jyh-Ming; YI-CHIA LEE ; Lin, Jaw-Town; Wu, Chun-Ying; Wu, Jeng-Yih; Lin, Chun-Hung; Fang, Yu-Ren; Luo, Jiing-Chyuan; TSU-YAO CHENG ; PING-HUEI TSENG ; HAN-MO CHIU ; Chang, Chun-Chao; Yu, Chien-Chun; Chiu, Min-Chin; YEN-NIEN CHEN ; Hu, Wen-Hao; Chou, Chu-Kuang; Tai, Chi-Ming; Lee, Ching-Tai; Wang, Wen-Lun; Chang, Wen-Shiung; Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Gastroenterology | 61 | 50 | |
2013 | Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; Chang C.-Y.; MEI-JYH CHEN ; YU-JEN FANG ; Lee J.-Y.; CHIEN-CHUAN CHEN ; SHIH-JER HSU ; Hsu Y.-C.; Tseng C.-H.; PING-HUEI TSENG ; Chang L.; Chang W.-H.; HSIU-PO WANG ; CHIA-TUNG SHUN ; Wu J.-Y.; YI-CHIA LEE ; Lin J.-T.; MING-SHIANG WU ; Lin C.-H.; LU-PING CHOW ; TSU-YAO CHENG ; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; CHIH-HSIEN WANG ; Kuo S.-H.; Wu C.-Y. | Journal of Antimicrobial Chemotherapy | 76 | 73 | |
2021 | The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota—a double-blind, placebo-controlled, randomized trial | MEI-JYH CHEN ; CHIEH-CHANG CHEN ; Huang Y.-C.; Tseng C.-C.; Hsu J.-T.; Lin Y.-F.; YU-JEN FANG ; MING-SHIANG WU ; JYH-MING LIOU ; for the Taiwan Gastrointestinal Disease, Helicobacter Consortium | Helicobacter | 16 | 14 | |
2020 | Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis | CHEN-HUA LIU ; Peng C.-Y.; YU-JEN FANG ; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Scientific Reports | 8 | 6 | |
2011 | Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; MEI-JYH CHEN ; Chang C.-Y.; YU-JEN FANG ; Lee J.-Y.; WANG-HUEI SHENG ; HSIU-PO WANG ; MING-SHIANG WU ; Lin J.-T. | Journal of Antimicrobial Chemotherapy | 40 | 40 | |
2024 | Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation | Tsai, Ying-Nan; Wu, Jia-Ling; Tseng, Cheng-Hao; Chen, Tzu-Haw; Wu, Yi-Ling; CHIEH-CHANG CHEN ; YU-JEN FANG ; Yang, Tzeng-Huey; Nguyen, Mindie H; JAW-TOWN LIN ; Hsu, Yao-Chun | Clinical and molecular hepatology | | | |
2017 | Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; YU-JEN FANG ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Open Forum Infectious Diseases | 42 | 39 | |
2022 | Identification of Early Esophageal Cancer by Semantic Segmentation | YU-JEN FANG ; Mukundan, Arvind; Tsao, Yu-Ming; Huang, Chien-Wei; Wang, Hsiang-Chen | Journal of personalized medicine | 26 | 18 | |
2017 | Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials | MEI-JYH CHEN ; MING-SHIANG WU ; CHIEN-CHUAN CHEN ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; WEN-FENG HSU ; Luo J.-C.; Lin J.-T.; JYH-MING LIOU ; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 21 | 20 | |
2016 | Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial | JYH-MING LIOU ; Bair M.-J.; CHIEH-CHANG CHEN ; YI-CHIA LEE ; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; Tseng C.-H.; YU-JEN FANG ; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; CHIA-TUNG SHUN ; WEN-FENG HSU ; Hung H.-W.; Lin J.-T.; Chang C.-Y.; MING-SHIANG WU | American Journal of Gastroenterology | 40 | 38 | |
2019 | Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; Chang, C.-M.; YU-JEN FANG ; Bair, M.-J.; Chen, P.-Y.; Chang, C.-Y.; Hsu, Y.-C.; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; Lee, J.-Y.; Yang, T.-H.; Luo, J.-C.; Chen, C.-Y.; WEN-FENG HSU ; YEN-NIEN CHEN ; Wu, J.-Y.; Lin, J.-T.; TZU-PIN LU ; Chuang, E.Y.; El-Omar, E.M.; MING-SHIANG WU ; Taiwan Gastrointestinal Disease; ERIC YAO-YU CHUANG | The Lancet Infectious Diseases | 125 | 111 | |
2020 | Microelimination of chronic hepatitis C by universal screening plus direct-acting antivirals for incarcerated persons in Taiwan | Yang T.-H.; YU-JEN FANG ; SHIH-JER HSU ; Lee J.-Y.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; CHIEN-HUNG CHEN | Open Forum Infectious Diseases | 24 | 25 | |
2023 | Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials | MEI-JYH CHEN ; Chen, Po-Yueh; YU-JEN FANG ; Bair, Ming-Jong; CHIEH-CHANG CHEN ; CHIEN-CHUAN CHEN ; Yang, Tsung-Hua; Lee, Ji-Yuh; Yu, Chien-Chun; Kuo, Chia-Chi; Chiu, Min-Chin; Chou, Chu-Kuang; Chen, Chi-Yi; Hu, Wen-Hao; Tsai, Min-Horn; Hsu, Yao-Chun; CHIA-TUNG SHUN ; Luo, Jiing-Chyuan; JAW-TOWN LIN ; El-Omar, Emad M; MING-SHIANG WU ; JYH-MING LIOU | The lancet. Gastroenterology & hepatology | 9 | 5 | |